Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

NCT04062565 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Treprostinil Injectable Product
DRUG: Riociguat Pill

Sponsor

University of Arizona